Previous Section
Drug Therapy
19. Determinants of daily insulin use in Type 1 diabetes.
- Author
- Muis MJ; Bots ML; Bilo HJ; Hoogma RP; Hoekstra JB; Grobbee DE; Stolk RP;
- Institution
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
- Journal
- J Diabetes Complications. 2006 Nov-Dec;20(6):356-60.
- Abstract URL
- Click here to view abstract
20. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
- Author
- Mathieu C;
- Institution
- UZ Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. chantal.mathieu@med.kuleuven.ac.be
- Journal
- Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):779-91.
- Abstract URL
- Click here to view abstract
21. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control.
- Author
- Zisser H; Jovanovic L;
- Institution
- Journal
- Diabetes Care. 2006 Sep;29(9):2175.
22. Apolipoprotein B as a long-term predictor of mortality in type 1 diabetes mellitus: a 15-year follow up.
- Author
- Stettler C; Suter Y; Allemann S; Zwahlen M; Christ ER; Diem P;
- Institution
- Division of Endocrinology and Diabetes, Department of Social and Preventive Medicine, University of Bern, Bern, Switzerland. christoph.stettler@insel.ch
- Journal
- J Intern Med. 2006 Sep;260(3):272-80.
- Abstract URL
- Click here to view abstract
Next: Clinical Trials
